Alere agreed to sell Alere Health, its health-management unit, to health-services provider Optum for $600 million in cash in order to focus on its core rapid diagnostics business.
C.R. Bard (NYSE:BCR) shares are up more than 3% this morning on Wall Street after the medical device company reported that its 3rd-quarter earnings rose 47.0% compared with the same period last year.